Rein Therapeutics Inc.
RNTX
$1.16
$0.043.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -472.78% | 18.19% | -24.01% | 86.58% | -600.89% |
| Total Depreciation and Amortization | -- | -100.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,470.49% | 621.48% | -3.03% | -99.29% | 7,209.65% |
| Change in Net Operating Assets | -239.78% | 26.53% | 115.67% | 2.70% | -163.42% |
| Cash from Operations | 9.24% | 44.72% | -3.94% | -28.33% | -26.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -200.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 68.97% | 73,700.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | 100.00% |
| Cash from Financing | 26.58% | -59.68% | 538.48% | 73,700.00% | 100.22% |
| Foreign Exchange rate Adjustments | 30.77% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.24% | 1.88% | 68.62% | -12.99% | -12.83% |